Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 9.87 USD 0.61%
Market Cap: 84.1m USD

Wall Street
Price Targets

STRO Price Targets Summary
Sutro Biopharma Inc

Wall Street analysts forecast STRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STRO is 39.05 USD with a low forecast of 8.08 USD and a high forecast of 105 USD.

Lowest
Price Target
8.08 USD
18% Downside
Average
Price Target
39.05 USD
296% Upside
Highest
Price Target
105 USD
964% Upside
Sutro Biopharma Inc Competitors:
Price Targets
IONS
Ionis Pharmaceuticals Inc
8% Upside
096530
Seegene Inc
71% Upside
VOR
Vor Biopharma Inc
198% Upside
4587
PeptiDream Inc
101% Upside
QTTB
Homology Medicines Inc
258% Upside
4593
Healios KK
128% Upside
2142
Hbm Holdings Ltd
2% Upside
RCKT
Rocket Pharmaceuticals Inc
135% Upside

Revenue
Forecast

Revenue Estimate
Sutro Biopharma Inc

For the last 7 years the compound annual growth rate for Sutro Biopharma Inc's revenue is 3%. The projected CAGR for the next 3 years is -12%.

3%
Past Growth
-12%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Sutro Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Sutro Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is STRO's stock price target?
Price Target
39.05 USD

According to Wall Street analysts, the average 1-year price target for STRO is 39.05 USD with a low forecast of 8.08 USD and a high forecast of 105 USD.

What is Sutro Biopharma Inc's Revenue forecast?
Projected CAGR
-12%

For the last 7 years the compound annual growth rate for Sutro Biopharma Inc's revenue is 3%. The projected CAGR for the next 3 years is -12%.

Back to Top